Modelled Economic Analysis for Dacomitinib–A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China

por Yu, Yong-feng, Luan, Luan, Zhu, Fan-fan, Dong, Peng, Ma, Li-Heng, Li, Lan-ting, Gao, Lan, Lu, Shun
Publicado 2021